HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

N- methyl- 1- (1,3- benzodioxol- 5- yl)- 2- butanamine (MBDB)

structure given in first source; RN given refers to (+-)-isomer
Also Known As:
MBDB; N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine, (R)-isomer; N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine, (S)-isomer
Networked: 6 relevant articles (0 outcomes, 3 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Ogata, Akio: 1 article (01/2009)
2. Nakagawa, Yoshio: 1 article (01/2009)
3. Suzuki, Toshinari: 1 article (01/2009)
4. Ishii, Hidemi: 1 article (01/2009)
5. Tayama, Sumiko: 1 article (01/2009)
6. Dexter, Simon P L: 1 article (08/2006)
7. Axon, Anthony T R: 1 article (08/2006)
8. Rotimi, Olorunda: 1 article (08/2006)
9. Lim, Chee H: 1 article (08/2006)
10. Deluca, Paolo: 1 article (05/2006)

Related Diseases

1. Barrett Esophagus (Barrett's Esophagus)
2. Neoplasms (Cancer)
3. Metaplasia
4. Seizures (Seizure)
5. Carcinoma (Carcinomatosis)

Related Drugs and Biologics

1. Methylene Blue (Methylthioninium Chloride)
2. Glutathione Disulfide (GSSG)
3. N-Methyl-3,4-methylenedioxyamphetamine (MDMA)
4. Methylcholanthrene
5. Glutathione (Reduced Glutathione)
6. Antigens
7. Adenosine Triphosphate (ATP)
8. Adenine
9. 3,4-methylenedioxyethamphetamine (MDEA)